Close menu

May 3rd, 2022 | 10:41 CEST

Tech stocks - Where is the party over? Alibaba, wallstreet:online, PayPal

  • Investments
  • Technology
  • Online
Photo credits:

For years, digital business models were considered the best of the best. But the past April has punished stocks such as Alibaba and PayPal - in some cases, very significantly. The question now is: Is the age of growth companies coming to an end, or are the current prices possibly a good opportunity? And what other factors might be playing a role?

time to read: 3 minutes | Author: Nico Popp

Table of contents:

    Alibaba: This China stock is in trouble

    Alibaba's stock has lost about 12% of its value over the course of a month. However, it is imperative to see the development in the context of the rapid rise in the share price at the end of March. The bottom line is that the weak April for Alibaba may have just been a correction. For months now, shares from China have been under pressure. First, Beijing's increasing interference caused a bad mood, and then more and more investors withdrew their capital because of it, which brought the China stocks into additional disrepute. But what is the fundamental situation of Alibaba?

    The Company is like a mixture of Amazon and eBay for the Chinese market. In addition, the Company also offers media and cloud services. In total, Alibaba has around 200 subsidiaries and employs 250,000 people. Due to its sheer size, Alibaba does not have to fear competition and has attracted many customers to its ecosystem, promoting intensive customer loyalty. Subsidiaries, such as its own logistics service provider Cainiao, perfectly complement the core areas and also earn money from the general trend towards more e-commerce. Alibaba remains a good stock. In the long term, however, the share is caught in a clear downward trend. In the short term, there are better alternatives.

    wallstreet:online: Progress, misjudged by the market

    When it comes to digital solutions, the name wallstreet:online always comes up among German small-cap investors. The company around the stock market portal of the same name has long had much more to offer than heated discussions about the latest hot stocks. The network now includes several financial websites and, with the Smartbroker, a brokerage solution that has been well received by customers and is intended to close the gap between modern neobrokers and established premium providers. In the meantime, Smartbroker is now 100% owned by wallstreet:online. That should be a prerequisite for additional business.

    Months ago, wallstreet:online announced that it wanted to integrate securities trading even more closely with its own media offering. Since wallstreet:online is considered the largest publisher-independent operator of stock market portals, this integration could be worthwhile. While the competition has to invest lavish marketing budgets, wallstreet:online keeps the money within the company. In the second half of the year, the broker plans to relaunch and offer customers new products and an innovative user experience. While the stock market is not doing so well these days, this could be an opportunity: wallstreet:online seems well-positioned to score even in a challenging market environment. The stock is 27% cheaper today than it was a year ago. From a chart perspective, a cautious stabilization is emerging.

    PayPal: Reasons for 60% loss in one year

    PayPal has also been on a minimal upward trend recently - but with a loss of 62.2% over the year, the stock is still in a bad way. What is the reason for the sell-off? Shares like PayPal got a boost from the pandemic. In the meantime, however, revenue growth is no longer as significant. In the first quarter, growth was only in the single digits, after values of over 20% during the pandemic. But does that justify share price losses of around 62% over the year? PayPal continues to have a working business model. It is possible that the stock was significantly overvalued a year ago, which is why the crash seems at least understandable.

    While both Alibaba and PayPal are severely battered in terms of chart performance from a long-term perspective, wallstreet:online's share price performance still looks positive on a three-year horizon. The share has lost ground but remains a success story. Since the Berlin-based company also seems to have a few operational arrows in its quiver, the stock could soon become interesting again.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 30th, 2022 | 10:59 CEST

    Biogen, XPhyto, BioNTech: Alzheimer's disease, depression, cancer - Pharma for life

    • Biotechnology
    • Pharma
    • Investments
    • Technology

    About 350 million people worldwide are affected by depression, a disorder of the brain. Each person also has a 16 to 20% chance of becoming depressed. Reason enough for the Canadian Company XPhyto Therapeutics to research a drug that is not addictive and can defeat the mental health-related medical condition. This week, Biogen, among others, achieved a breakthrough with an active substance against Alzheimer's disease. And if you follow the Bundesliga closely, you may be aware of the cases of testicular cancer among the players. Now BioNTech senses a new opportunity...


    Commented by Fabian Lorenz on September 29th, 2022 | 13:17 CEST

    Up to 200% share price potential: Kion, BioNTech, Aspermont in analyst check

    • Technology
    • Biotechnology
    • Investments

    The profit warning was a shock for Kion shareholders. Accordingly, the share price halved to EUR 20 in September alone. Now analysts are also slashing their estimates. The price targets for the forklift manufacturer are falling accordingly. Berenberg surprises with a high price target for the BioNTech share. At the same time, the analysts emphasize their hope for a continued generous dividend. Shareholders could thus be kept in good spirits until the next blockbuster. The roadshow of Aspermont in Germany has probably also created a good mood. At least the share price has jumped. The current consolidation could be an entry opportunity. Analysts see a price potential of over 200%.


    Commented by Carsten Mainitz on September 29th, 2022 | 12:01 CEST

    Verbio, Kleos Space, KWS Saat - This news is moving share prices!

    • Space
    • Technology
    • Investments

    Increased uncertainties in geopolitics, rampant inflation with exploding commodity and energy prices, and higher interest rates are making it increasingly difficult for companies to meet the forecasts they issued at the beginning of the year. Recent examples include battery manufacturer Varta and real estate financier Hypoport, which had to withdraw their annual targets. In addition, however, a number of companies have been able to surprise on the upside despite all the challenges.